The nation of Zimbabwe has declined a significant American health deal valued at 367 million US dollars (272 million pounds) over five years over the United States' insistence on sensitive data.
This rejection was revealed after a internal memorandum dated December was disclosed, revealing that President Emmerson Mnangagwa felt the arrangement was "lopsided".
A government spokesperson later explained that the US was requesting health data for scientific study and commercial purposes but was unwilling to guarantee the benefits from any future medical innovations.
"We must now begin the difficult and regrettable process of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for further dialogue to reach a agreement agreeable to both sides so the country's vital HIV programme can continue.
Wider Implications
This rejection follows a comparable case in neighbouring Kenya, where a court blocked a similar deal with the US following legal challenges were raised about the safety of citizens' health data.
After resuming the presidency last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had managed aid for the American government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to boost transparency and responsibility.
Based on reports, Sixteen African countries have so far signed these new health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment via US-supported programmes," Tremont said.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"Zimbabwe was being asked to share its biological resources and data over an extended period, without any equivalent assurance of benefiting from any medical innovations – like new medicines or tests – that could be developed from that shared data," his statement read.
"Put simply, our country would supply the raw materials for scientific discovery without any certainty that the final treatments would be available to our citizens if a future pandemic arise."
Sovereignty and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were upending structures already set up via the international organization.
Mangwana cited its Pandemic Benefit-Sharing system designed to manage future pandemics.
"This framework is intended to ensure that when a country contributes its information, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the funds to develop them."
Zimbabwe's reservations over the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We welcome further dialogue with our American counterparts on how future co-operation might be structured in a way that respects the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but suggested that negotiations should continue considering much of the nation's HIV programmes relied on foreign aid.
"Where technical issues arise, such as those relating to information security or implementation frameworks, these can often be addressed via technical clarification and negotiated safeguards," the group commented.
This impasse emphasises the ongoing debate between accepting vital foreign assistance and safeguarding national sovereignty in an ever more data-driven world.